FINWIRES · TerminalLIVE
FINWIRES

Kimberly-Clark First-Quarter Results Top Views; Full-Year Outlook Affirmed

作者

-- Kimberly-Clark (KMB) reported better-than-expected first-quarter results and maintained its full-year outlook Tuesday, while the consumer goods maker flagged potential incremental input cost headwinds of up to $170 million in the second half due to elevated oil prices.

The Kleenex tissues maker's adjusted earnings attributable to the company rose to $1.97 a share for the March quarter from $1.93 a year earlier, which was the consensus on FactSet. Net sales improved 2.7% to $4.16 billion, topping the Street's view for $4.09 billion.

The company's shares were up 1.1% in Tuesday afternoon trade. So far this year, the stock has lost 1.6% in value.

Kimberly-Clark said it continues to expect full-year adjusted EPS from continuing operations to grow at a double-digit rate, while adjusted EPS attributable to Kimberly-Clark are still seen flat, both on a constant-currency basis.

The company also continues to expect 2026 organic sales to grow in line to ahead of the weighted average growth in the categories and countries it competes, which for the latest 12 months grew at roughly 2.5%, it said.

Kimberly-Clark could face gross incremental input cost headwinds of between $150 million and $170 million in the second half of the year, if oil prices stay at the $100 a barrel level, Chief Financial Officer Nelson Urdaneta said in prepared remarks on the company's website.

Energy prices have soared following the US-Israel war with Iran that started at the end of February, with the Strait of Hormuz -- the world's most important chokepoint for crude flows -- effectively closed. The conflict paused following a recent ceasefire between the US and Iran and later between Israel and Lebanon.

Kimberly-Clark's first-quarter international personal care business revenue climbed 9.1% to $1.51 billion, buoyed by organic sales growth of 4% and favorable currency impacts. Sales in North America fell 0.6% to $2.65 billion, driven by a 2.7% headwind from the exit of the company's private label diaper business in the US, partially offset by organic sales growth of 1.8%.

"We continued to deliver solid volume-plus-mix performance while building share momentum despite continued geopolitical and macroeconomic uncertainty," Chief Executive Mike Hsu said in a statement. "We continue to generate meaningful cost savings that reinforce our strong financial foundation and enable us to invest in our exciting future."

For the second quarter, Kimberly-Clark expects to incur a $50 million headwind related to a recent fire at its Ontario, California, distribution center, "as well as some incremental costs due to the conflict in the Middle East," Urdaneta said. "We expect to fully mitigate these costs in the second half of the year with the many levers available within our integrated margin management capabilities."

Price: $99.40, Change: $+1.15, Percent Change: +1.17%

相关文章

Sectors

行业动态:科技股午后下跌

周二下午晚些时候,科技股下跌,其中道富科技精选行业SPDR ETF (XLK)下跌1.5%,道富SPDR标普半导体ETF (XSD)下跌4.4%。 费城半导体指数下跌3.3%。 公司新闻方面,《华尔街日报》周一晚间援引知情人士消息报道称,OpenAI近期未能实现其新增用户和营收目标。科技巨头英伟达(NVDA)下跌1.2%,博通(AVGO)下跌4.2%,AMD下跌3.1%,甲骨文(ORCL)下跌3.6%,英特尔(INTC)下跌1.4%。 据路透社报道,上周美国商务部致函Lam Research (LRCX)、Applied Materials (AMAT)和KLA (KLAC)等芯片设备公司,要求其停止向中国第二大芯片制造商华虹公司交付某些工具。Lam Research股价下跌3%,Applied Materials下跌5.1%,KLA下跌4.1%。 彭博社周二援引亚马逊网络服务首席执行官马特·加曼在彭博电视台采访中的话报道称,在微软放弃独家转售ChatGPT制造商OpenAI产品的权利后,亚马逊(AMZN)计划向其客户提供OpenAI的人工智能模型。亚马逊股价下跌0.6%,微软股价上涨0.6%。 Spotify Technology (SPOT)公布的第一季度利润超出预期,但其付费用户增长和前景令投资者失望。该股下跌12%。

$AMAT$AMD$AMZN$AVGO$INTC$KLAC$LRCX$MSFT$NVDA$ORCL$SPOT
Australia

Erasca股价在初步1期剂量递增数据公布后下跌

周二,Erasca (ERAS) 股价暴跌 48%,此前该公司公布了其试验性药物 ERAS-0015 在 RAS 突变型实体瘤(包括结直肠癌、非小细胞肺癌和胰腺腺癌)患者中进行的 1 期剂量递增试验的初步数据。 该公司表示,来自美国和中国正在进行的试验的初步数据显示,ERAS-0015 可能与标准剂量的帕尼单抗联合使用,使其成为未来联合治疗方案的潜在骨干疗法。 声明称,该疗法总体“耐受性良好”,未出现剂量限制性毒性或因不良事件导致的治疗中断。 Erasca 表示,已选择每日一次 24 毫克和 32 毫克作为进一步研究的推荐剂量,并称该药物与帕尼单抗联合使用显示出“令人鼓舞的临床潜力”。 该公司在一份监管文件中表示,一名66岁男性患者死亡,该患者患有转移性胰腺腺癌,此前接受过大量治疗。该公司称,根据患者本人的决定,停止支持治疗后,该患者3级治疗相关不良事件——肺炎——进展为5级。Price: $9.96, Change: $-9.20, Percent Change: -48.02%

$ERAS
Commodities

美国能源部计划斥资4.3亿美元,对212个水力发电设施进行升级改造。

美国能源部周一表示,计划拨款近4.3亿美元,用于支持212个设施的293个水电项目,旨在加强电网可靠性和基础设施建设。 能源部称,水力发电和水动力办公室将重启谈判,根据“维护和增强水力发电激励计划”分配资金。 能源部表示,该计划支持旨在提高电网韧性、增强大坝安全性并确保符合州和联邦法规的升级改造。 能源部补充说,这笔资金加上私人资本,有望推动水力发电总投资达到约28亿美元。 水力发电占美国公用事业规模电力供应的5.86%,而抽水蓄能占大型储能的88%,通过允许运营商快速调整输出并平衡供需,从而支持电网稳定。 能源部表示,尽管运营成本低,但许多设施由于基础设施老化限制了性能,因此需要进行现代化改造。 该部门表示,项目将包括对涡轮机、发电机和溢洪道进行改进,以延长运行寿命并以具有竞争力的成本满足未来的电力需求。 该部门表示,该计划使水电设施能够在不增加用户成本的情况下升级关键基础设施,从而解决日益增长的电网可靠性、安全性和可负担性问题。 该机构表示,相关办公室将开始审查申请,并计划在未来几个月内开始发放款项。